Evidence map›Paper›PMID 39445325›Full record

ArticleThe Journal of clinical and aesthetic dermatology2024

Diagnostic Delay of Psoriatic Arthritis of More Than Six Months Contributes to Poor Patient-Reported Outcome Measures in Depression, Social Ability, and Disease Impact: A Cross-sectional Study.

Melissa P Zundell, Lourdes Perez-Chada, Neel Tapryal, George C Gondo, M Elaine Husni, Gretchen D Ball, Michael J Woodbury, Joseph F Merola, Alice B Gottlieb

Abstract read
In one paragraph

Article in The Journal of clinical and aesthetic dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Molecular Link Between Psoriasis and Depression-Update on Pathophysiology.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Melissa P ZundellMses. Zundell and Ball and Dr. Gottlieb are with the Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York.
Lourdes Perez-ChadaDr. Perez-Chada, Mr. Woodbury, and Dr. Merola are with the Department of Dermatology at Brigham and Women's Hospital at Harvard Medical School in Boston, Massachusetts.
Neel TapryalDrs. Tapryal and Husni are with the Department of Rheumatologic and Immunologic Disease at the Cleveland Clinic in Cleveland, Ohio.
George C GondoMr. Gondo is with the National Psoriasis Foundation in Alexandria, Virginia.
M Elaine HusniDrs. Tapryal and Husni are with the Department of Rheumatologic and Immunologic Disease at the Cleveland Clinic in Cleveland, Ohio.
Gretchen D BallMses. Zundell and Ball and Dr. Gottlieb are with the Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York.
Michael J WoodburyDr. Perez-Chada, Mr. Woodbury, and Dr. Merola are with the Department of Dermatology at Brigham and Women's Hospital at Harvard Medical School in Boston, Massachusetts.
Joseph F MerolaDr. Perez-Chada, Mr. Woodbury, and Dr. Merola are with the Department of Dermatology at Brigham and Women's Hospital at Harvard Medical School in Boston, Massachusetts.
Alice B GottliebMses. Zundell and Ball and Dr. Gottlieb are with the Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: We sought to correlate the time lag between psoriatic arthritis (PsA) symptom onset and diagnosis to the likelihood and severity of depression, social impairment, and disease impact on quality of life. Methods: This cross-sectional study conducted by the National Psoriasis Foundation (NPF) surveyed individuals with PsA using patient-reported outcome measures. Results: The analysis cohort comprised 2,196 patients with PsA. Likelihood of depression progressively increased when time between PsA symptom onset and diagnosis was beyond six months (28.6% <6 months; 29.6% 7-12 months; 38.1% 13-24 months; 35.4% >2 years; Limitations: The study only includes participants who were active members of the NPF, and all data was self-reported. Conclusion: Our results demonstrate that delays between PsA symptom onset and diagnosis that are greater than six months lead to increased likelihoods of depression, social disengagement, and impaired quality of life, and that longer delays lead to increasingly worse outcomes in these domains.

Indexed as

depressiondiagnostic delaydisease impactpatient-reported outcome measuresPsoriatic arthritisquality of lifesocial participation

Identifiers

PMID39445325
PMCPMC11495158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.